Modifiable Risk Factors and Residual Risk Following Coronary Revascularization: Insights From a Regionalized Dedicated Follow-Up Clinic.
Mayo Clin Proc Innov Qual Outcomes
; 5(6): 1138-1152, 2021 Dec.
Article
en En
| MEDLINE
| ID: mdl-34934904
ACS, acute coronary syndrome; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CAPITAL, Cardiovascular And Percutaneous clinical TriALs; DM, diabetes mellitus; HR, hazard ratio; HbA1c, hemoglobin A1C; MACE, major adverse cardiovascular event; MI, myocardial infarction; NSTEMI, non-ST elevation MI; PCI, percutaneous coronary intervention; STEMI, ST elevation MI; UA, unstable angina
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Idioma:
En
Revista:
Mayo Clin Proc Innov Qual Outcomes
Año:
2021
Tipo del documento:
Article
País de afiliación:
Canadá